SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001590750-19-000051
Filing Date
2019-10-31
Accepted
2019-10-31 17:00:27
Documents
3
Period of Report
2019-10-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K mgen-201910318k.htm 8-K 45297
2 EXHIBIT 10.1 mgen201910318kexhibit1.htm EX-10.1 39911
3 MGEN LOGO image11.jpg GRAPHIC 5076
  Complete submission text file 0001590750-19-000051.txt   93895
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36483 | Film No.: 191184368
SIC: 8071 Services-Medical Laboratories